no statement of use filed
on 08 Apr 2019
Last Applicant/ Owned by
2440 Research Boulevard
Rockville
MD
20850
Serial Number
86786801 filed on 13th Oct 2015
Registration Number
N/A
Correspondent Address
B. BRETT HEAVNER
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Educational services, namely, conducting educational programs and providing courses about central nervous system diseases, disorders and treatment; on-line publishing of electronic publications; on-line journals, namely, blogs about central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment Electronic materials, namelRead More
Electronic materials, namely, downloadable brochures, pamphlets, and videos about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment
Printed materials, namely, brochures, pamphlets and posters about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment
Raising awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients and healthcare professionals related to health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment
Providing financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders
Educational services, namely, conducting educational programs and providing courses about central nervous system diseases, disorders and treatment; on-line publishing of electronic publications; on-line journals, namely, blogs about central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment
Providing patient support in the nature of medical information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; discharge planning support, namely, providing medical advice to patients and healthcare providers regarding future treatment scheduling; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders
No 86786801
No Service Mark
No 09843.0086-0
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 08th Apr 2019 | ABANDONMENT - NO USE STATEMENT FILED |
| 08th Apr 2019 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 08th Sep 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 06th Sep 2018 | EXTENSION 4 GRANTED |
| 06th Sep 2018 | TEAS EXTENSION RECEIVED |
| 06th Sep 2018 | EXTENSION 4 FILED |
| 08th Mar 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 06th Mar 2018 | EXTENSION 3 GRANTED |
| 06th Mar 2018 | TEAS EXTENSION RECEIVED |
| 06th Mar 2018 | EXTENSION 3 FILED |
